FDA-approved drug might prevent relapse in male alcoholics
Mifepristone, a drug approved by the U.S. Food and Drug Administration for terminating early pregnancy, might prove effective in preventing stress-induced relapse in recovering male alcoholics, based on findings in rats reported by researchers at the Ernest Gallo Clinic and Research Center at UCSF.
Mifepristone was originally marketed under the name RU-486. It blocks the activity of progesterone and cortisol, hormones that, in the brain, are thought to play a role in promoting alcoholism as well as relapse.
Its well-known that stress can lead to relapse in people who are trying not to drink, said senior author Selena E. Bartlett, PhD, director of medications development at the Gallo Center. Until now, we have had very few interventions that showed potential as possible treatments.
In an experiment reported online Nov. 2, 2011 in Neuropsychopharmacology, Bartlett and her research team trained a group of male rats to drink either an alcohol solution or a sucrose solution on demand by pressing a lever. The rats were then conditioned not to press the lever to seek the reward of a drink a process sort of like rehabilitation in humans, according to Bartlett.
After this period of forced abstinence, the rats were given yohimbine, a compound known to induce stress and relapse-like behavior in rodents.
We wanted to see if the stressed rats would press the lever again, much as a stressed alcoholic in recovery might reach for a drink, said Bartlett.
Some of the rats were given injections of mifepristone before being given yohimbine. Those animals were significantly less likely to press the lever for a drink when compared with rats not given mifepristone.
In order to pinpoint exactly where the mifepristone was acting in the rats brains, Bartlett and her team repeated the experiment but this time, before administering yohimbine, they infused mifepristone directly into the central nucleus of the amygdala, a brain structure known to play a role in stress, anxiety and anxiety disorders. This brain region has been shown to be a critical area for the control of fear responses, as well as the center of individual emotional experience.
This was a very unexpected finding, but very exciting, said Bartlett. Identifying the area of the brain where mifepristone acts to discourage alcoholic relapse opens up the possibility of creating new compounds that are even more specific in their action.
Currently, Bartlett and her team are working to determine which hormone mifepristone specifically blocks in discouraging relapse: cortisol or progesterone. We are working to obtain funding to enable testing of this medication in male alcoholics, she said.
Provided by University of California, San Francisco
- FDA-approved drug shows promise as alcoholism treatment Jan 12, 2011 | not rated yet | 0
- Excessive drinking and relapse rapidly cut in new approach Jun 09, 2008 | not rated yet | 0
- Cocaine addiction linked to voluntary drug use and cellular memory Jul 30, 2008 | not rated yet | 0
- Biochemical pathway may link addiction, compulsive eating Sep 01, 2010 | not rated yet | 0
- Brain circuitry that drives drug-seeking compulsion identified Feb 06, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research May 17, 2013 | 3.7 / 5 (3) | 0 |
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research May 17, 2013 | 5 / 5 (1) | 0
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research May 17, 2013 | 4 / 5 (1) | 0 |
Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.
Medical research May 17, 2013 | 4 / 5 (1) | 0 |
A new Montréal study conducted by Dr. May Faraj, associate research professor at the Université de Montréal and invited scientist at the IRCM, along with her research team and medical collaborators, shows ...
Medical research May 17, 2013 | not rated yet | 0 |
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
9 minutes ago | not rated yet | 0
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
1 hour ago | not rated yet | 0
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
9 hours ago | not rated yet | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
9 hours ago | 4.7 / 5 (3) | 0 |
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
9 hours ago | not rated yet | 1
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
9 hours ago | not rated yet | 0